相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers
Y. Wattanagoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics and tolerability of oseltamivir combined with probenecid
Mark Holodniy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Population pharmacokinetics of oseltamivir when coadministered with probenecid
Craig R. Rayner et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects
Jerome J. Schentag et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetics of oseltamivir in young and very elderly subjects
Masaichi Abe et al.
ANNALS OF PHARMACOTHERAPY (2006)
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis
Richard Robson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate
P Snell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Safety and pharmacology of oseltamivir in clinical use
R Dutkowski et al.
DRUG SAFETY (2003)
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids
P Snell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin
C Oo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion - Correlation of in vivo and in vitro studies
G Hill et al.
DRUG METABOLISM AND DISPOSITION (2002)
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
S Bantia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
IA Leneva et al.
ANTIVIRAL RESEARCH (2000)
分享论文
